Reports for GLAXOSMITHKLINE INC
Company Name
GLAXOSMITHKLINE INC
Totals |
||
Shortage reports |
325 |
|
Actual shortage: | 9 (3%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 6 (2%) | |
Resolved: | 310 (95%) | |
Discontinuation Reports |
57 |
|
To be discontinued: | 2 (4%) | |
Discontinued: | 55 (96%) | |
Reversed: | 0 (0%) | |
Late reports |
4 (1%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
IMITREX | 5MG | SPRAY | Resolved | 2018-10-26 | 2018-10-31 | 65623 |
IMITREX | 5MG | SPRAY | Resolved | 2021-06-30 | 2021-07-10 | 141713 |
IMITREX | 5MG | SPRAY | Resolved | 2021-12-10 | 2022-01-26 | 150930 |
IMITREX | 20MG | SPRAY | Resolved | 2017-04-06 | 2017-05-26 | 5841 |
IMITREX | 20MG | SPRAY | Resolved | 2017-06-06 | 2018-02-23 | 12156 |
IMITREX | 20MG | SPRAY | Resolved | 2018-03-09 | 2018-04-27 | 42337 |
IMITREX | 20MG | SPRAY | Resolved | 2019-04-18 | 2019-05-17 | 82069 |
IMITREX | 20MG | SPRAY | Resolved | 2020-04-03 | 2020-04-30 | 110863 |
IMITREX | 20MG | SPRAY | Resolved | 2022-01-05 | 2022-02-10 | 152121 |
IMITREX | 20MG | SPRAY | Resolved | 2022-03-11 | 2022-03-30 | 156574 |
INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2019-02-19 | 2019-03-02 | 76337 |
INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2019-12-18 | 2020-02-06 | 101563 |
INCRUSE ELLIPTA | 62.5MCG | POWDER | Resolved | 2022-12-16 | 2023-01-04 | 178691 |
JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2018-12-12 | 2019-02-22 | 69396 |
JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2019-05-17 | 2019-08-16 | 84337 |
JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2020-02-21 | 2020-03-26 | 106829 |
JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2021-11-26 | 2022-03-02 | 149987 |
JALYN | 0.4MG 0.5MG | CAPSULE (IMMEDIATE AND EXTENDED RELEASE) | Actual shortage | 2023-11-23 | 2024-05-09 | 211335 |
LAMICTAL | 150MG | TABLET | Resolved | 2017-08-23 | 2018-03-16 | 20136 |
LAMICTAL | 100MG | TABLET | Resolved | 2018-03-16 | 2018-05-26 | 43073 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ENGERIX-B | 20MCG | SUSPENSION | Discontinued | 2019-12-10 | 2020-05-27 | 100904 |
ENGERIX-B | 10MCG | SUSPENSION | Discontinued | 2019-12-10 | 2020-04-30 | 100907 |
FLONASE - AEM-SUS NAS 50MCG/MD | 50MCG | METERED-DOSE PUMP | Discontinued | 2017-08-02 | 2018-10-17 | 18117 |
FORTAZ | 1G | POWDER FOR SOLUTION | Discontinued | 2020-12-22 | 2020-12-22 | 130594 |
FORTAZ | 2G | POWDER FOR SOLUTION | Discontinued | 2020-12-22 | 2020-12-22 | 130597 |
FORTAZ | 6G | POWDER FOR SOLUTION | Discontinued | 2020-12-22 | 2020-12-22 | 130600 |
HEPTOVIR | 100MG | TABLET | Discontinued | 2022-05-13 | 2022-08-10 | 160500 |
HEPTOVIR | 5MG | SOLUTION | Discontinued | 2022-05-13 | 2022-07-22 | 160503 |
HIBERIX | 10MCG | POWDER FOR SOLUTION | Discontinued | 2022-11-18 | 2023-03-29 | 175258 |
INFANRIX-IPV | 32UNIT 8UNIT 40UNIT 40UNIT 30UNIT 8MCG 25MCG 25MCG | SUSPENSION | Discontinued | 2021-10-28 | 2021-10-28 | 148433 |
MENJUGATE | Discontinued | 2018-10-23 | 2018-10-24 | 65487 | ||
MESASAL | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2017-03-17 | 2017-03-24 | 3333 |
NERISONE OILY CREAM | 0.1% | CREAM | Discontinued | 2017-04-25 | 2017-04-26 | 8092 |
NERISONE OILY CREAM | 0.1% | CREAM | Discontinued | 2017-04-25 | 2017-04-26 | 8096 |
NUCALA | 100MG | POWDER FOR SOLUTION | Discontinued | 2023-12-07 | 2023-12-07 | 212755 |
PAXIL TAB 10MG | 10MG | TABLET | To be discontinued | 2024-04-05 | 2024-04-05 | 224405 |
PAXIL TAB 30MG | 30MG | TABLET | To be discontinued | 2024-04-05 | 2024-04-05 | 224430 |
PREVEX B | Discontinued | 2017-11-24 | 2017-11-24 | 30611 | ||
REQUIP | 0.25MG | TABLET | Discontinued | 2017-09-19 | 2017-11-01 | 22594 |
REQUIP | 1MG | TABLET | Discontinued | 2017-09-19 | 2018-03-15 | 22597 |